Letter: addition of methotrexate neither restores clinical response nor improves the pharmacokinetic profile of vedolizumab-treated patients

被引：12
作者：
Gouynou, C.
Peyrin-Biroulet, L. [1 ]
机构：
[1] Lorraine Univ, Nancy Univ Hosp, Dept Gastroenterol & Hepatol, Vandoeuvre Les Nancy, France
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2017年 / 46卷 / 10期
关键词：
INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; IMMUNOMODULATOR; INFLIXIMAB; ANTIBODIES; THERAPY;
D O I：
10.1111/apt.14320
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1019 / 1020
页数：2
相关论文
共 5 条
[1]   Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease [J].
Ben-Horin, Shomron ;
Waterman, Matti ;
Kopylov, Uri ;
Yavzori, Miri ;
Picard, Orit ;
Fudim, Ella ;
Awadie, Halim ;
Weiss, Batia ;
Chowers, Yehuda .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (04) :444-447
[2]   Addition of an Immunomodulator as a Rescue Therapy for Loss of Response to Adalimumab Dose Escalation in Patients With Crohn's Disease [J].
Papamichael, Konstantinos ;
Karatzas, Pantelis ;
Mantzaris, Gerassimos J. .
JOURNAL OF CROHNS & COLITIS, 2015, 9 (07) :589-590
[3]   Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience [J].
Peyrin-Biroulet, Laurent ;
Salleron, Julia ;
Filippi, Jerome ;
Reenaers, Catherine ;
Antunes, Ophelie ;
Filipe, Virginie ;
Louis, Edouard ;
Hebuterne, Xavier ;
Roblin, Xavier .
JOURNAL OF CROHNS & COLITIS, 2016, 10 (05) :516-524
[4]   Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease [J].
Sandborn, William J. ;
Feagan, Brian G. ;
Rutgeerts, Paul ;
Hanauer, Stephen ;
Colombel, Jean-Frederic ;
Sands, Bruce E. ;
Lukas, Milan ;
Fedorak, Richard N. ;
Lee, Scott ;
Bressler, Brian ;
Fox, Irving ;
Rosario, Maria ;
Sankoh, Serap ;
Xu, Jing ;
Stephens, Kristin ;
Milch, Catherine ;
Parikh, Asit .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :711-721
[5]   Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease [J].
Strik, A. S. ;
van den Brink, G. R. ;
Ponsioen, C. ;
Mathot, R. ;
Loewenberg, M. ;
D'Haens, G. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) :1128-1134
1